Memory and thinking tests during CAR-T therapy
Part of Blood & lymphatic, Cancer, Immune system & allergy clinical trials.
This study looks at how CAR-T cell therapy affects memory and thinking skills in adults with certain types of lymphoma. The results may help doctors understand and support patients better during treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have one of these lymphomas: diffuse large B-cell lymphoma, high-grade B-cell lymphoma, primary mediastinal B-cell lymphoma, or a lymphoma that changed from a slower-growing type.
- Your lymphoma has come back or hasn't gone away, and you are scheduled to receive CAR-T cell therapy (a treatment using your own immune cells).
- You do not have lymphoma in your brain or spinal cord.
- You have not had radiation to your brain or spinal cord.
- You do not have a serious mental health or brain condition that would make the tests hard to complete.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies a type of immune therapy (CAR T-cells) for people whose leukemia or lymphoma has come back or did not respond after at least two treatment attempts. It aims to improve outcomes in carefully selected patients who can safely receive the treatment.
This study looks at how well CAR-T cell therapy works and how safely it can be given to older adults. It is for people whose cancer or related blood condition has come back or did not respond, and who are receiving a standard (commercial) CAR-T product.
This trial tests a new type of CAR-T cell therapy that may be better at remembering and attacking lymphoma cells. It is for people with large B-cell lymphoma that has not responded to standard treatments or has come back.
This study looks at how lymphoma treatment may affect thinking and memory years after therapy. It aims to understand and support long-term survivors.
This trial tests a personalized cancer treatment called CAR-T therapy. It uses your own immune cells, which are modified in a lab to fight your specific type of blood cancer, and then given back to you. The goal is to see if this treatment is safe and feasible when produced locally.
This trial tests a new treatment called Anbalcabtagene Autoleucel (a type of CAR-T cell therapy) for people whose B-cell lymphoma has come back or not responded to treatment, specifically when it affects the brain or spinal cord. The goal is to see if this therapy can help control the disease.
Hear when a new High-grade B-cell Lymphoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.